Login / Signup

Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Trial.

Xianzhi ZhaoYu-Tian XiaoYue YangYusheng YeYifan ChangLingong JiangMd EftekharShancheng RenHuojun Zhang
Published in: Cancer control : journal of the Moffitt Cancer Center (2022)
Chinese Clinical Trial Registry, ChiCTR1900025743. http://www.chictr.org.cn/showprojen.aspx?proj=43065.
Keyphrases
  • clinical trial
  • prostate cancer
  • open label
  • phase ii
  • rectal cancer
  • study protocol
  • double blind
  • randomized controlled trial
  • radical prostatectomy
  • lymph node
  • phase iii
  • locally advanced
  • lymph node metastasis